Bolt Biotherapeutics
Phase 1Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.
Founded
2015
Focus
AntibodiesBiologics
About
Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.
Funding History
3Total raised: $248.3M
IPO$100.8MUndisclosedFeb 5, 2021
Series B$54MSofinnova InvestmentsJul 15, 2019
Series A$93.5MNovo VenturesJan 15, 2018
Company Info
TypePrivate
Founded2015
LocationRedwood City, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile